A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas occur in a familial setting, either in isolated or syndromic form. Recently, loss-of-function mutations in genes encoding succinate dehydrogenase subu...
Autores principales: | Michelle Maher, Federico Roncaroli, Nigel Mendoza, Karim Meeran, Natalie Canham, Monika Kosicka-Slawinska, Birgitta Bernhard, David Collier, Juliana Drummond, Kassiani Skordilis, Nicola Tufton, Anastasia Gontsarova, Niamh Martin, Márta Korbonits, Florian Wernig |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Bioscientifica
2018-07-01
|
Colección: | Endocrinology, Diabetes & Metabolism Case Reports |
Acceso en línea: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-18-0078 |
Ejemplares similares
-
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
por: Ali S. Alzahrani, et al.
Publicado: (2023-12-01) -
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
por: Lambert, K, et al.
Publicado: (2017) -
Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
por: Lambert, K, et al.
Publicado: (2017) -
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
por: Yiqiang Huang, et al.
Publicado: (2018-11-01) -
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
por: Gill AJ
Publicado: (2012-04-01)